Abstract:Senescence is a driver of aging and various age‐related diseases. However, tracking and visualizing of senescence in vivo is very challenging. We have rationally developed a near‐infrared (NIR) fluorescent probe (XZ1208) that can be cleaved rapidly by ß‐galactosidase (ß‐Gal) and produces a strong fluorescence signal. XZ1208 achieved high specificity, sensitivity and a long‐term duration in labeling senescence without causing significant toxicities in multiple aging and senescence‐associated disease models. Senescent cells (SnCs) are implicated in aging and various age‐related pathologies. Targeting SnCs can treat age‐related diseases and extend health span. However, precisely tracking and visualizing of SnCs is still challenging, especially in in vivo environments. Here, we developed a near‐infrared (NIR) fluorescent probe (XZ1208) that targets β‐galactosidase (β‐Gal), a well‐accepted biomarker for cellular senescence. XZ1208 can be cleaved rapidly by β‐Gal and produces a strong fluorescence signal in SnCs. We demonstrated the high specificity and sensitivity of XZ1208 in labeling SnCs in naturally aged, total body irradiated (TBI), and progeroid mouse models. XZ1208 achieved a long‐term duration of over 6 days in labeling senescence without causing significant toxicities and accurately detected the senolytic effects of ABT263 on eliminating SnCs. Furthermore, XZ1208 was applied to monitor SnCs accumulated in fibrotic diseases and skin wound healing models. Overall, we developed a tissue‐infiltrating NIR probe and demonstrated its excellent performance in labeling SnCs in aging and senescence‐associated disease models, indicating great potential for application in aging studies and diagnosis of senescence‐associated diseases.

A renal clearable fluorogenic probe for in vivo β-galactosidase activity detection during aging and senolysis

A rapid-response near-infrared fluorescent probe with a large Stokes shift for senescence-associated β-galactosidase activity detection and imaging of senescent cells

Ratiometric Fluorescent Probe for Real-Time Detection of β-Galactosidase Activity in Lysosomes and Its Application in Drug-Induced Senescence Imaging

Fluorogenic Labeling Probe for the Imaging of Endogenous β-Galactosidase Activity in Cancer and Senescent Cells

<i>In Vivo</i> Imaging of Senescent Vascular Cells in Atherosclerotic Mice Using a -Galactosidase-Activatable Nanoprobe

A rationally designed fluorescence probe achieves highly specific and long‐term detection of senescence in vitro and in vivo

Kill Two Birds with One Stone: A Near-Infrared Ratiometric Fluorescent Probe for Simultaneous Detection of Β-Galactosidase in Senescent and Cancer Cells

Β-Galactosidase-activatable Fluorescent and Photoacoustic Imaging of Tumor Senescence.

Revelation of Β-Galactosidase Variation in Senile Sperms and Organs Via a Silicon Xanthene Near-Infrared Probe

Novel PET Imaging Probe for Quantitative Detection of Senescence In Vivo

A Near-Infrared Fluorescent Probe for Fast and Precise Imaging of Senescent Cells and Ovarian Cancer Cells Via Tracking Β-Galactosidase

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

An Activatable NIR Probe for the Detection and Elimination of Senescent Cells

First-generation Species-Selective Chemical Probes for Fluorescence Imaging of Human Senescence-Associated Β-Galactosidase.

Is Senescence-Associated β-Galactosidase a Reliable in vivo Marker of Cellular Senescence During Embryonic Development?

A Senolysis-Based Theragnostic Prodrug Strategy Towards Chronic Renal Failure

Fluorescent Probes for Diagnostics of β-Galactosidase: From Micro to Macro

A near-infrared fluorescent nanoprobe for senescence-associated β-galactosidase sensing in living cells

Noninvasive NIR Imaging of Senescence via In Situ Labeling

Development of a specific fluorescent probe to detect advanced glycation end products (AGEs)

Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice